Resection and Reconstruction for Breast Cancer

Dear Colleagues,

Breast cancer is the most common malignancy found in women; according to GLOBOCAN, there were nearly 2.3 million of new cases diagnosed in 2022 and 670,000 deaths, respectively. Therefore, early diagnosis through proper screening, oncologic vigilance and education across the globe and proper combined modality treatment are vital.

This also means that breast cancer is a curable disease and there is a vast number of survivors, with many living with various consequences following therapy.

Surgery is a cornerstone of combined modality treatment and cannot be omitted in any case. Oncoplastic surgery (Audretsch), the integration of plastic surgery techniques for reshaping of the breast immediately after cancer eradication, allows us to decrease the positive margin rate and to obtain better aesthetics, and thus a higher quality of life. Oncoplastic techniques allow us to decrease the breast deformity rate following wide excisions. Breast reconstruction, either immediate or secondary to mastectomy and either implant-based and using autologous tissues, allows us to avoid mutilation. Being the oldest method of cancer therapy, surgery is very dynamic and there have been many changes in surgical strategies and techniques in this field in the last few decades.

There are two pillars of successful treatment in oncology: survival and the quality of life. Both have been successfully improved by modern surgery of the breast in frames of combined modality treatment.

For this special issue of Cancers, we welcome manuscripts covering surgical treatment of this very special and numerous group of patients: women touched by breast cancer.

Dr. Radoslaw Tarkowski
Dr. Gilles Houvenaeghel
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.